Anti-Influenza B virus HA/Hemagglutinin Reference Antibody (Lesofavumab, RUO)

SKU: VK515056

Size:100ug

Description:Lesofavumab is a recombinant monoclonal antibody to Influenza B virus hemagglutinin. Lesofavumab is a human monoclonal antibody that can be potentially used in the treatment of Influenza B infection. Genentech, a subsidiary of Roche, is developing Lesofavumab (RG6024), a monoclonal antibody, for the treatment of influenza B infections.

Host species:Human

Tested applications:

Species reactivity:Influenza B virus

Form:Liquid

Storage buffer:0.01M PBS, pH 7.4.

Purity:>95% purity as determined by SDS-PAGE.

Clonality:Monoclonal

Isotype:IgG1, kappa

Applications:ELISA, Bioactivity: FACS, Functional assay, Research in vivo

Target:HA/Hemagglutinin

Purification:Protein A/G purified from cell culture supernatant.

Endotoxin level:Please contact us for this information.

Expression system:Mammalian Cells

Accession:P03461

Stability and Storage:Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.

Reconstitution:

Background:

Alternative Names:RG6024, RG6024, MHAB5553A, RG70026, RO7045557, 1807960-57-1

Clone ID:

Species:

Note:For research use only. Not suitable for clinical or therapeutic use.